Skip to content
BetaNetwork

The Zimbabwean Government Turns Down ‘Lopsided’ American Healthcare Assistance Agreement Over Data Apprehensions

Health aid image
The proposed American financial assistance would have supported programmes for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has turned down a significant US health deal worth 367 million US dollars (272 million pounds) over five years due to the United States' demand for sensitive data.

This move came to light after a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the deal was "unbalanced".

An official representative later clarified that the United States was seeking genetic material for scientific study and commercial gain while refused to share the benefits from any future treatments.

"We must now begin the challenging and unfortunate process of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had donated over $1.9bn in health funding to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for more dialogue to reach a agreement suitable to both sides so the country's critical HIV programme can continue.

Wider Background

This rejection follows a similar case in Kenya, where a high court suspended a similar health funding agreement after legal challenges were raised about the security of Kenyans' medical information.

Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.

USAID had managed aid for the American government, but Trump argued its spending was "inefficient" and his government was pursuing government-to-government deals to boost openness and accountability.

As per reports, 16 nations in Africa have to date agreed to similar agreements, representing over $18.3bn in new funding.

Specifics of the Rejected Agreement

The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this partnership would have delivered immense advantages for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment via US-supported initiatives," Tremont commented.

However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".

"Our nation was requested to share its genetic material and health information for a long time, with no equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.

"Effectively, our nation would provide the basic resources for scientific discovery without any certainty that the end products would be accessible to our people if a future disease outbreak arise."

Sovereignty and International Frameworks

Mangwana further said that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting systems previously established via the international organization.

Mangwana cited its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.

"This framework is designed to ensure that when a country contributes its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."

Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We are open to continued discussions with our US partners on how subsequent collaboration could be structured in a manner that honours the sovereignty and dignity of both nations."

Medical Community Reaction

Medical experts said it recognised the official position, but recommended that negotiations must proceed considering a large portion of the country's HIV programmes relied on international support.

"If technical issues arise, such as those relating to information security or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," it said.

The halted deal underscores the complex challenges between receiving vital international aid and protecting national sovereignty in an ever more data-driven world.

The writer

David Simpson

A technology strategist and AI researcher with over a decade of experience in digital innovation and startup ecosystems.

BetaNetwork

Type to search articles.